Eric Dishman, who has led the ambitious All of Us Research Program of the National Institutes of Health, has announced he will transition to a role as chief innovation officer, as the search for a new director begins.
Before working at NIH on the agency’s efforts to build a national research program of 1 million or more U.S. participants to advance precision medicine, Dishman was an Intel fellow and vice president of the Health and Life Sciences Group at Intel Corp., where he was responsible for driving global strategy, research and development, product and platform development, and policy initiatives for health and life science solutions.
In a blog post, Dishman said that when a new leader has been selected, he will become the program’s chief innovation officer, driving the strategic and user-centered development of new program features. “This will give me the opportunity to continue to bring in new methods and processes for innovation from my 25-year career in Silicon Valley. As someone treated for cancer for 23 years and a transplantee, this will be an opportunity for me to focus on staying healthy over the long term and spend more time wearing my ‘patient advocate’ hat, engaging directly with our participants and community partners.”
Dishman noted that the change also represents the evolution of the program from a start-up to a more established organization with an emphasis on enhancing the All of Us experience for participants and researchers alike.
A nationwide search will begin this week for a new director/chief executive officer to lead the program into its next phase.
